Carvedilol in the treatment of elderly patients with chronic heart failure

Klaus KA Witte1, Andrew L Clark21Academic Department of Cardiology, LIGHT Building, University of Leeds and Leeds General Infirmary, UK; 2Academic Department of Cardiology, Castle Hill Hospital, University of Hull, Hull, UKAbstract: Chronic heart failure (CHF) is common, and increases in incidence a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Klaus KA Witte, Andrew L Clark
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/4489500f74044df798aa28c82bbfd687
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4489500f74044df798aa28c82bbfd687
record_format dspace
spelling oai:doaj.org-article:4489500f74044df798aa28c82bbfd6872021-12-02T00:38:34ZCarvedilol in the treatment of elderly patients with chronic heart failure1178-1998https://doaj.org/article/4489500f74044df798aa28c82bbfd6872008-03-01T00:00:00Zhttps://www.dovepress.com/carvedilol-in-the-treatment-of-elderly-patients-with-chronic-heart-fai-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Klaus KA Witte1, Andrew L Clark21Academic Department of Cardiology, LIGHT Building, University of Leeds and Leeds General Infirmary, UK; 2Academic Department of Cardiology, Castle Hill Hospital, University of Hull, Hull, UKAbstract: Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain undertreated. The aim of the present article is to review the potential mechanisms of the benefits of adrenergic blockade in CHF and the clinical data available from the large randomized studies, focusing particularly on older patients.Keywords: beta-blockers, chronic heart failureKlaus KA WitteAndrew L ClarkDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 3, Pp 55-70 (2008)
institution DOAJ
collection DOAJ
language EN
topic Geriatrics
RC952-954.6
spellingShingle Geriatrics
RC952-954.6
Klaus KA Witte
Andrew L Clark
Carvedilol in the treatment of elderly patients with chronic heart failure
description Klaus KA Witte1, Andrew L Clark21Academic Department of Cardiology, LIGHT Building, University of Leeds and Leeds General Infirmary, UK; 2Academic Department of Cardiology, Castle Hill Hospital, University of Hull, Hull, UKAbstract: Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain undertreated. The aim of the present article is to review the potential mechanisms of the benefits of adrenergic blockade in CHF and the clinical data available from the large randomized studies, focusing particularly on older patients.Keywords: beta-blockers, chronic heart failure
format article
author Klaus KA Witte
Andrew L Clark
author_facet Klaus KA Witte
Andrew L Clark
author_sort Klaus KA Witte
title Carvedilol in the treatment of elderly patients with chronic heart failure
title_short Carvedilol in the treatment of elderly patients with chronic heart failure
title_full Carvedilol in the treatment of elderly patients with chronic heart failure
title_fullStr Carvedilol in the treatment of elderly patients with chronic heart failure
title_full_unstemmed Carvedilol in the treatment of elderly patients with chronic heart failure
title_sort carvedilol in the treatment of elderly patients with chronic heart failure
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/4489500f74044df798aa28c82bbfd687
work_keys_str_mv AT klauskawitte carvedilolinthetreatmentofelderlypatientswithchronicheartfailure
AT andrewlclark carvedilolinthetreatmentofelderlypatientswithchronicheartfailure
_version_ 1718403550148558848